Grifols, S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GRFS research report →
About the company
Grifols, S. A. , a company founded in 1940 and headquartered in Barcelona, Spain, specializes in the development, manufacture, and distribution of therapeutic products, with a primary focus on those derived from human plasma.
- CEO
- Jose Ignacio Abia Buenache
- IPO
- 2011
- Employees
- 23,833
- HQ
- Barcelona, ES
Price Chart
- Market Cap
- $6.06B
- P/E
- 14.78
- P/S
- 0.83
- P/B
- 1.12
- EV/EBITDA
- 10.54
- Div Yield
- 0.91%
- Gross Margin
- 37.68%
- Op Margin
- 16.89%
- Net Margin
- 5.58%
- ROE
- 7.88%
- ROIC
- 5.49%
- Revenue
- $7.23B · 0.20%
- Net Income
- $386.13M · 146.07%
- EPS
- $0.57 · 147.83%
- Op Income
- $1.19B
- FCF YoY
- 41.51%
- 52W High
- $11.14
- 52W Low
- $6.96
- 50D MA
- $7.74
- 200D MA
- $8.66
- Beta
- 1.18
- Avg Volume
- 677.49K
Get TickerSpark's AI analysis on GRFS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our GRFS coverage
Recent articles, reports, and earnings notes.
No research on GRFS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GRFS report →Similar companies
Peers in the same neighborhood.